rna antagonists targeting hsp27

• 收藏
• 分享

专利权人:

SANTARIS PHARMA A/S;ENZON PHARMACEUTICALS, INC.

发明人:

JESPER WORM

申请号：

BRPI0914123

公开号：

BRPI0914123A2

申请日:

2009.07.01

申请国别(地区):

BR

年份:

2015

代理人:

摘要：

The present invention relates to oligomer compounds (oligomers), which target Hsp27 mRNA in a cell, leading to reduced expression of Hsp27. Reduction of Hsp27 expression is beneficial for the treatment of certain medical disorders, such as cancer. The invention provides therapeutic compositions comprising oligomers and methods for modulating the expression of Hsp27 using the oligomers, including methods of treatment.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/